IONIS PHARMACEUTICALS INC

By person

28 insiders · 648 transactions

11.9×

Brett P. Monia holds 11.9 times base salary in stock. $12.53M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Brett P. Monia last reported holding, valued at $51.60, the price Common Stock was last bought or sold at on the open market here, on 31 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Monia Brett P

Chief Executive Officer

—

$60.06M (60) scheduled

−$60.06M

242,760

0.1461%

$12.53M

+3,096%

CROOKE STANLEY T

Exec Chairman of the Board

—

$46.32M (113) scheduled

−$46.32M

1,202,384

0.7235%

$62.04M

−14.1%

BENNETT C FRANK

EVP, Chief Scientific Officer

—

$30.87M (45) scheduled

−$30.87M

60,128

0.0362%

$3.10M

+281.3%

O'NEIL PATRICK R.

EVP CLO & General Counsel

—

$30.65M (81) scheduled

−$30.65M

59,205

0.0356%

$3.05M

+523.7%

HOUGEN ELIZABETH L

EVP, Finance & CFO

—

$27.53M (36) scheduled

−$27.53M

82,660

0.0497%

$4.27M

+1,170%

Geary Richard S

EVP, Chief Development Officer

—

$23.43M (43) scheduled

−$23.43M

59,657

0.0359%

$3.08M

+603.3%

PARSHALL B LYNNE

Director

—

$17.35M (33) scheduled

−$17.35M

51,344

0.0309%

$2.65M

+207.6%

KLEIN JOSEPH III

Director

—

$12.81M (50) scheduled

−$12.81M

11,014

0.0066%

$568.32K

+43.8%

Swayze Eric

EVP Research

—

$11.07M (31) scheduled

−$11.07M

22,077

0.0133%

$1.14M

+2,904%

WENDER JOSEPH H

Director

—

$10.14M (17) scheduled

−$10.14M

52,035

0.0313%

$2.69M

−15.8%

Devers Shannon L.

EVP, Chief Human Resources Ofc

—

$8.99M (16) scheduled

−$8.99M

16,348

0.0098%

$843.56K

+106.7%

LOSCALZO JOSEPH

Director

—

$8.56M (7) scheduled

−$8.56M

36,330

0.0219%

$1.87M

+654.7%

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

—

$7.94M (15) scheduled

−$7.94M

77,114

0.0464%

$3.98M

+192.0%

Baroldi Joseph

EVP, Chief Business Officer

—

$7.09M (25) scheduled

−$7.09M

49,578

0.0298%

$2.56M

+1,065%

Diaz Allene M.

Director

—

$5.39M (8) scheduled

−$5.39M

3,811

0.0023%

$196.65K

—

BERTHELSEN SPENCER R

Director

—

$4.88M (9) scheduled

−$4.88M

161,233

0.0970%

$8.32M

+103.2%

Kordasiewicz Holly B.

EVP, Chief Development Officer

—

$4.81M (4) scheduled

−$4.81M

22,096

0.0133%

$1.14M

+42.7%

Birchler Brian

EVP, Corp and Development Ops

—

$4.04M (11) scheduled

−$4.04M

102,883

0.0619%

$5.31M

+45.6%

Jenne Kyle

EVP, Chf GL Pdt Str Ofcr

—

$3.42M (5) scheduled

−$3.42M

23,713

0.0143%

$1.22M

+1,092%

MUTO FREDERICK T

Director

—

$3.37M (7) scheduled

−$3.37M

59,597

0.0359%

$3.08M

+713.6%

HERMAN JOAN E

Director

—

$3.17M (2) scheduled

−$3.17M

51,306

0.0309%

$2.65M

—

Hayden Michael R

Director

$1.72M (5)

—

+$1.72M

78,298

0.0471%

$4.04M

+1,857%

Cadoret-Manier Onaiza

EVP, Chf GL Pdt Str & Oper Ofc

—

$687.39K (5)

−$687.39K

35,825

0.0216%

$1.85M

—

Castleman Breaux

Director

—

$600.00K (1) scheduled

−$600.00K

19,183

0.0115%

$989.84K

+110.6%

Boyce Sarah

Chief Business Officer

—

$176.67K (3)

−$176.67K

8,931

0.0054%

$460.84K

+317.7%

Reikes Peter N

Director

—

14,222

0.0086%

$733.86K

—

YANG MICHAEL J.

Director

—

7,940

0.0048%

$409.70K

—

McDevitt Damien

Chief Business Officer

—

2,573

0.0015%

$132.77K

—

IONIS PHARMACEUTICALS INC

By person

Individual transactions

What was left out